| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.1M | +51.6% |
| SG&A Expense | $4.8M | -20.1% |
| Operating Income | -$18.9M | -23.6% |
| Interest Expense | $14K | +96.5% |
| Income Tax | $0 | — |
| Net Income | -$18.9M | -23.4% |
| EPS (Basic) | -$5.00 | +55.4% |
| EPS (Diluted) | -$5.00 | +55.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $549K | -94.5% |
| Current Assets | $1.6M | -87.3% |
| Total Assets | $1.7M | -87.0% |
| Current Liabilities | $6.1M | +24.6% |
| Total Liabilities | $6.1M | +24.6% |
| Stockholders' Equity | -$4.4M | -154.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.1M | -33.9% |
| Capital Expenditures | $4K | -11.8% |
| Investing Cash Flow | -$4K | +11.8% |
| Financing Cash Flow | $4.6M | -70.3% |
| Free Cash Flow | -$14.1M | -33.9% |